We work at the interface of biology and engineering to develop new medical devices and human therapies. We create nanoparticles that can deliver genetic therapy inside of cells and even perform genome editing in vivo. We also develop living therapeutics, constructed from human cells and biomaterials, that can provide long-term therapy for chronic diseases like diabetes. Finally, we create smart biomaterials and responsive drug delivery systems that can integrate with the body and provide customized, on-demand treatment for patients.
Latest News
-
William and team win Koch Institute Image Award
William's microscopy of the foreign body response in action is on display now in the Koch Institute Public Galleries.
-
Oxygen-permeable skeletons breathe life into implanted cell therapies
A hybrid encapsulation system for engineered cells enhances their ability to secrete therapeutics long-term.
-
Dan elected to National Academy of Inventors
Dan Anderson is elected to the National Academy of Inventors in recognition of inventions that have made a tangible impact on society.